Home > PE Ratio > IPCA LABORATORIES

IPCA LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of IPCA LABORATORIES is 43.23.

Share Price ₹1,467.2Dec 12,2025
Market Cap ₹37,221.6 Cr
Earnings-TTM₹861.0 CrTTM-Consolidated Results
Price/Earnings43.23xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of IPCA LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of IPCA LABORATORIES is calculated as :

Current Market Cap [ ₹37,221.6 Cr] as on Dec 12,2025

(/) Earnings [ ₹861.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 43.23x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for IPCA LABORATORIES , the investors are currently willing to pay 43.23 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of IPCA LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of IPCA LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of IPCA LABORATORIES


PE Ratio Performance Analysis for IPCA LABORATORIES

- IPCA LABORATORIES 's latest p/e ratio is 43.23x.

- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 38.74x.

- IPCA LABORATORIES 's operated at median p/e ratio of 43.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2024 at 57.39x.

- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 10.59x.


How does IPCA LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
IPCA LABORATORIES 861.0343.2337,221.6
SUN PHARMACEUTICAL INDUSTRIES LTD10,517.9040.93430,513.0
DIVIS LABORATORIES LTD2,485.0068.66170,614.0
CIPLA LTD5,453.8622.47122,555.0
TORRENT PHARMACEUTICALS LTD2,140.0059.93128,245.0
DR REDDYS LABORATORIES LTD5,721.4018.67106,803.0
MANKIND PHARMA LTD1,767.0650.9289,972.9
ZYDUS LIFESCIENCES LTD4,973.4018.8093,484.2
LUPIN LTD4,347.5322.2196,571.8
AUROBINDO PHARMA LTD3,447.7520.1169,330.3
ABBOTT INDIA LTD1,508.9539.3759,412.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs IPCA LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.67x
Max industry PE 68.66x
Median industry PE 39.37x
Average industry PE 36.84x



You may also like the below Video Courses